Seventh Replenishment Investment Case; Fight For What Counts

Over the past 20 years, our unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from HIV, tuberculosis (TB) and malaria by more than half in the countries in which the Global Fund invests.

For the Seventh Replenishment, the Global Fund needs at least US$18 billion. This is the minimum required to get the world back on track toward ending HIV, TB and malaria, to build resilient and sustainable systems for health and strengthen pandemic preparedness, making the world more equitable and safer from future threats.
 

The stakes could not be higher. The last two years have been a vivid demonstration of how old and new pandemics interact. COVID-19 has been a catastrophe for those most affected by HIV, TB and malaria. If we do not meet our new investment target, many more people will die from these pandemics and be at risk from future health threats.

These funds are needed to change the trajectories of mortality and incidence toward achieving the SDG 3 target of ending AIDS, TB and malaria as epidemics by 2030, build stronger and more resilient health systems and strengthen capacities to prevent and prepare for future pandemics. By taking an integrated approach to the pursuit of these complementary objectives, we can maximize the impact of every dollar.

The Global Fund’s target for the Seventh Replenishment is to raise at least US$18 billion. This scale of investment is essential: If we do not reach this goal, we will fail.